IMMD Insider Trading Activity and SEC Form 4 Filings
IMMD insider trading summary
No open-market insider purchases or sales of Immudyne, Inc. (IMMD) have been reported on SEC Form 4 in the past 12 months.
Latest IMMD insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 23, 2018 | Justin Schreiber | Chief Executive Officer | Buy | $18K (80,000 @ $0.22) |
| May 22, 2018 | Justin Schreiber | Chief Executive Officer | Buy | $5K (22,600 @ $0.23) |
| May 22, 2018 | Justin Schreiber | Chief Executive Officer | Buy | $561 (2,400 @ $0.23) |
| Mar 27, 2018 | Justin Schreiber | Chief Executive Officer | Buy | $55K (212,500 @ $0.26) |
| Feb 13, 2018 | Mark McLaughlin | 10% Owner | Sell | $69K (298,407 @ $0.23) |
| Feb 13, 2018 | Mark McLaughlin | 10% Owner | Sell | $22K (96,593 @ $0.23) |
| Feb 13, 2018 | Mark McLaughlin | 10% Owner | Sell | $3K (15,000 @ $0.23) |
| Feb 13, 2018 | Mark McLaughlin | 10% Owner | Sell | $7K (31,504 @ $0.23) |
| Feb 13, 2018 | Mark McLaughlin | 10% Owner | Sell | $7K (31,582 @ $0.23) |
| Feb 13, 2018 | Mark McLaughlin | 10% Owner | Sell | $7K (31,410 @ $0.23) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.